US Stock MarketDetailed Quotes

OKYO OKYO Pharma

Watchlist
  • 1.095
  • +0.030+2.82%
Close Feb 14 16:00 ET
  • 1.080
  • -0.015-1.37%
Post 20:01 ET
37.16MMarket Cap-2.88P/E (TTM)

OKYO Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OKYO Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 0.000--
--2025/Q3-- / 0.000--
--2025/Q20.000 / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--

Unlock Free Earnings Estimates

OKYO Pharma Earnings Reports

  • OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Jan 29 16:36 ET

  • OKYO Pharma | 20-F: FY2024 Annual Report

    Aug 13, 2024 16:36 ET

  • OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 21, 2023 07:35 ET

  • OKYO Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 18, 2023 16:56 ET

    • Read more

    Trending Stocks

    Top Gaining Chinese Stocks Top Gaining Chinese Stocks
    No. Symbol % Chg
    XINGANJIANG
    873167
    +30.00%
    INNOVATIVE DATA
    835305
    +29.98%
    CHENGUANG MEDICAL
    430300
    +29.96%
    4
    Hangzhou Gaoxin Materials Technology
    300478
    +20.04%
    5
    Beijing Philisense Technology
    300287
    +20.03%
    Log In for the Full List
    Unlock Now
    Investment Course
    Top 5 Industries for Stock Trading under Trump's Second Term
    Stocks & Industries to Watch Under Trump's Second Presidency
    With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
    Monetary Policy: Navigating the Fed's Rate Cut Cycle
    Changing Fed policy is altering the market math for investors.
    Discussing
    Tesla's earnings caused fluctuations, what's your market outlook？
    Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
    TSLA earnings preview: Grab rewards by guessing the opening price!